COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2016

Apr 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2016-04-05

Reporting Person: Heffernan Michael Thomas (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-05	Common Stock	M	9673	$3.31	Acquired	383117	Direct
2016-04-05	Common Stock	M	3931	$.48	Acquired	387048	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-05	Stock Option (Right to Purchase)	$3.31	M	9673	Disposed	2020-11-11	Common Stock (9673)	Direct
2016-04-05	Stock Option (Right to Purchase)	$.48	M	3931	Disposed	2023-01-30	Common Stock (3931)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	163043	Indirect

Footnotes

F1: Shares held by Island View Investors, LLC. Mr. Heffernan is the sole member of Island View Investors, LLC.

F2: All 9,673 options are exercisable.

F3: The options vest and become exercisable in equal installments (rounded up to the nearest whole option) at the end of each month over a 4-year period commencing on January 24, 2013. The option was initially for 14,492 options and the option was previously exercised as to 7,548 options.